https://www.selleckchem.com/pr....oducts/mitomycin-c.h
Tumor size and N stage were independent risk factors affecting the survival of cPN patients. cPN for patients with tumor size 7 cm or N1 stage may present a higher risk of death. Conclusion The implementation of cPN for patients with EmRCC who meet specific clinical characteristics such as tumors size ≤7 cm, N0 stage, or isolated metastases seems to help improve the survival prognosis. © 2020 Chen et al.Purpose The main purpose of the study was to determine the level of correlation between self-reported and measured physical fit
Gefällt mir
Kommentar
Teilen
